Benzinga · Sep 1, 2026
UBS Maintains Neutral on Morgan Stanley Direct, Lowers Price Target to $15.5
UBS analyst Doug Harter maintains Morgan Stanley Direct (NYSE:MSDL) with a Neutral and lowers the price target from $16.25 to $15.5.
NYSE · MSDL
Financial Services · Financial - Conglomerates
$14.71
Up+$0.07 (+0.48%)
Updated Sep 13, 2026, 11:10 PM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
MSDL closed at $14.71 after 19 trading sessions, down 4.23% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $14.75 | $14.82 | $14.62 | $14.71 | 283.27K |
| Sep 10, 2026 | $14.75 | $14.84 | $14.555 | $14.64 | 289.71K |
| Sep 9, 2026 | $15.00 | $15.14 | $14.75 | $14.77 | 395.46K |
| Sep 8, 2026 | $15.26 | $15.26 | $15.01 | $15.04 | 1.24M |
| Sep 4, 2026 | $15.16 | $15.32 | $15.13 | $15.25 | 189.37K |
| Sep 3, 2026 | $15.40 | $15.40 | $15.11 | $15.20 | 315.44K |
| Sep 2, 2026 | $15.29 | $15.36 | $15.2001 | $15.27 | 395.35K |
| Sep 1, 2026 | $15.34 | $15.40 | $15.215 | $15.25 | 339.76K |
| Aug 31, 2026 | $15.15 | $15.455 | $15.11 | $15.35 | 391.96K |
| Aug 28, 2026 | $15.25 | $15.39 | $15.18 | $15.18 | 267.28K |
| Aug 27, 2026 | $15.29 | $15.43 | $15.28 | $15.32 | 444.12K |
| Aug 26, 2026 | $15.35 | $15.40 | $15.23 | $15.26 | 274.04K |
| Aug 25, 2026 | $15.43 | $15.445 | $15.2903 | $15.38 | 571.7K |
| Aug 24, 2026 | $15.35 | $15.42 | $15.24 | $15.37 | 569.98K |
| Aug 21, 2026 | $15.40 | $15.47 | $15.35 | $15.36 | 242.89K |
| Aug 20, 2026 | $15.37 | $15.45 | $15.26 | $15.38 | 244.71K |
| Aug 19, 2026 | $15.40 | $15.52 | $15.32 | $15.37 | 343.6K |
| Aug 18, 2026 | $15.42 | $15.485 | $15.31 | $15.37 | 349.75K |
| Aug 17, 2026 | $15.36 | $15.449 | $15.23 | $15.36 | 696.99K |
The latest Smart Investors Daily articles mentioning MSDL.
MSDL research
Company profile and research snapshot.
Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 1, 2026 | UBS | Neutral | — |
| Jul 2, 2026 | JP Morgan | Neutral | — |
| Apr 20, 2026 | UBS | Neutral | — |
| Apr 16, 2026 | Keefe, Bruyette & Woods | Market Perform | — |
| Mar 13, 2026 | JP Morgan | Neutral | — |
No generated briefing is available yet.
Benzinga · Sep 1, 2026
UBS analyst Doug Harter maintains Morgan Stanley Direct (NYSE:MSDL) with a Neutral and lowers the price target from $16.25 to $15.5.
Yahoo · Aug 31, 2026
The overlapping portion of Business Development Company funds has risen from about 10% of the average portfolio in 2010 to over 55% today.
SeekingAlpha · Aug 22, 2026
SeekingAlpha · Aug 13, 2026
Morgan Stanley Direct Lending Fund's Q2 2026 results signal weaker dividend coverage, NAV decline, and rising non-accruals. Click here to read this MSDL update.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning MSDL.